ID
12420
Description
A Non-interventional, Post Marketing Surveillance (PMS) Study of Tresiba® (Insulin Degludec) to Evaluate Long Term Safety and Efficacy in Patients With Diabetes Mellitus in Routine Clinical Practice in India; ODM derived from: https://clinicaltrials.gov/show/NCT02117622
Link
https://clinicaltrials.gov/show/NCT02117622
Keywords
Versions (1)
- 11/17/15 11/17/15 -
Uploaded on
November 17, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes NCT02117622
Eligibility Diabetes NCT02117622
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Allergy
Data type
boolean
Alias
- UMLS CUI [1]
- C0020517
Description
Study Subject Participation Status
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
Description
Mental incapacity
Data type
boolean
Alias
- UMLS CUI [1]
- C2229018
Description
Tresiba® therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C3491971
Description
Patients who are participating in other studies or clinical trials
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
Description
Patients who are pregnant
Data type
boolean
Alias
- UMLS CUI [1]
- C3242212
Similar models
Eligibility Diabetes NCT02117622
- StudyEvent: Eligibility
No comments